HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,454,005 | +81.4% | 118,225 | -1.3% | 8.68% | +62.5% |
| Q3 2022 | $7,417,000 | -22.6% | 119,836 | -0.2% | 5.34% | -15.2% |
| Q2 2022 | $9,578,000 | -25.3% | 120,090 | -1.4% | 6.30% | -7.3% |
| Q1 2022 | $12,819,000 | -0.9% | 121,840 | +1.5% | 6.80% | +6.7% |
| Q4 2021 | $12,931,000 | -0.9% | 119,995 | +0.7% | 6.37% | -3.5% |
| Q3 2021 | $13,053,000 | +16.6% | 119,161 | -0.3% | 6.60% | +15.4% |
| Q2 2021 | $11,192,000 | -48.8% | 119,526 | -49.7% | 5.72% | -9.0% |
| Q1 2021 | $21,852,000 | +118.1% | 237,422 | +73.4% | 6.28% | +8.9% |
| Q4 2020 | $10,018,000 | -17.9% | 136,954 | -12.8% | 5.77% | -36.8% |
| Q3 2020 | $12,195,000 | +30.7% | 156,994 | -6.5% | 9.13% | +14.3% |
| Q2 2020 | $9,333,000 | +73.9% | 167,928 | -7.3% | 7.99% | +24.4% |
| Q1 2020 | $5,366,000 | -19.0% | 181,168 | -1.0% | 6.42% | +9.6% |
| Q4 2019 | $6,627,000 | +41.8% | 183,054 | +6.7% | 5.86% | +28.6% |
| Q3 2019 | $4,673,000 | – | 171,621 | – | 4.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paulson & Co. | 6,100,000 | $377,529,000 | 27.63% |
| Kopp Family Office, LLC | 542,543 | $33,578,000 | 27.33% |
| Prosight Management, LP | 303,000 | $18,753,000 | 10.05% |
| Eversept Partners, LP | 1,269,591 | $78,574,987 | 6.81% |
| Octagon Capital Advisors LP | 624,500 | $38,650,000 | 6.67% |
| Avoro Capital Advisors LLC | 5,125,000 | $317,186,000 | 5.86% |
| 1492 Capital Management LLC | 119,836 | $7,417,000 | 5.34% |
| Velan Capital Investment Management LP | 68,829 | $4,260,000 | 4.22% |
| Deep Track Capital, LP | 1,462,800 | $90,533,000 | 4.15% |
| Ally Bridge Group (NY) LLC | 74,262 | $4,596,000 | 3.03% |